NYT
F.D.A. Seeks More Oversight of Vaccine Trials and Approvals
By Christina Jewett from NYT Health https://ift.tt/rgW3O4j via IFTTT
NYT
A Different Type of Dementia is Changing What’s Known About Cognitive Decline
By Pam Belluck and Morgan Hornsby from NYT Health https://ift.tt/jTRu1w6 via IFTTT
NYT
U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
By Rebecca Robbins from NYT Health https://ift.tt/u6SRPTg via IFTTT
NYT
Doctor Critical of Vaccines Quietly Appointed as C.D.C.’s Second in Command
By Apoorva Mandavilli from NYT Health https://ift.tt/9mBXtx0 via IFTTT
NYT
C.D.C. Changes Website to Reflect Kennedy’s Vaccine Skepticism
By John Yoon from NYT Health https://ift.tt/gwM8hXC via IFTTT
NYT
Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs
By Dani Blum and Rebecca Robbins from NYT Health https://ift.tt/z5L1Sxh via IFTTT
NYT
Nolan Williams, Who Stimulated the Brain to Treat Depression, Dies at 43
By Richard Sandomir from NYT Health https://ift.tt/FHcXPrt via IFTTT
NYT
The Young Women Grappling With an ‘Old Man’s Disease’
By Roni Caryn Rabin and Lucy Lu from NYT Health https://ift.tt/ocTHzbJ via IFTTT
NYT
F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause
By Roni Caryn Rabin from NYT Health https://ift.tt/vQ1HypZ via IFTTT
NYT
New Pill From Merck Could Slash Cholesterol Levels, Trials Show
By Gina Kolata from NYT Health https://ift.tt/ukgOVlc via IFTTT
NYT
The ‘Worst Test in Medicine’ is Driving America’s High C-Section Rate
By Sarah Kliff from NYT Health https://ift.tt/Is0HhDp via IFTTT
NYT
Obesity Drugs May Drop to as Little as $149 a Month
By Rebecca Robbins, Margot Sanger-Katz and Dani Blum from NYT Health https://ift.tt/g…
NYT
F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Company
By Christina Jewett from NYT Health https://ift.tt/bs81lwa via IFTTT
Social Plugin